Francisco Felipe de Magalhães

Francisco Felipe de Magalhães

Auto-generated profile, based on publicly available information

Francisco Felipe de Magalhães

Universidade Estadual do Ceará, Brasil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Animal Reproduction
Verified
Journal Article
Open access
BPBreno Queiroz Pinheiro
Breno Queiroz Pinheiro
FMFrancisco Felipe de Magalhães
Francisco Felipe de Magalhães
FAFrancisco Wesley da Silva Alves
Francisco Wesley da Silva Alves
ISIsaac Neto Goes Silva
Isaac Neto Goes Silva
AFAugusto Faustino
Augusto Faustino
LSLucia Daniel Machado da Silva
Lucia Daniel Machado da Silva
The identification of putative prognostic factors in canine mammary neoplasms (CMNs) has been focused on tissue-specific biomarkers, but the serum biomarkers, including cancer antigen 15-3 (CA 15-3), c-reactive protein (CRP), and lactate dehydrogenase (LDH) have been demonstrated to display clinical application in cases of CMNs. The aim of the study was to evaluate the levels of these serum biomarkers and their association with well-established prognostic factors in CMNs. Samples from 15 female canines with CMNs and 15 clinically healthy ones were collected. The results were evaluated using the Tukey's, Pearson, or Spearman tests. The cut-off point, sensitivity, specificity, and area under curve (AUC) were evaluated using the receiver operating characteristic (ROC) curve analysis in a logistic regression model (P<0.05). The levels of CA 15-3, CRP and LDH were significantly higher in the serum of female dogs with CMNs compared to the healthy ones. Moreover, these factors were positively correlated with ulceration, tumor size, histopathological grade, metastatic lymph node, and clinical staging. Female dogs with CMNs were found to exhibit highest serum levels of CA 15-3, CRP, and LDH. Therefore, they can be applied to improve the efficacy of the diagnosis and prognostic evaluation in casas of CMNs.